| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | $5.00K | $2.50K | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $4.37M | $2.92M | $310.09K | $8.48M | $309.00K | $326.00K |
| R&D | $1.61M | $1.33M | – | – | – | – |
| SG&A | $890.05K | $331.72K | $54.33K | $196.50K | $83.74K | – |
| Operating Income | -$4.37M | -$2.92M | -$307.59K | -$8.48M | -$309.00K | -$326.00K |
| Interest Expense | – | – | – | $382.00 | – | – |
| Tax Expense | – | – | – | – | – | – |
| Net Income | -$4.00M | -$2.90M | -$298.20K | -$8.47M | -$287.00K | -$326.00K |
| EPS (basic) | -0.2200 | -0.3200 | -0.0300 | -1.4300 | -0.3000 | -0.0100 |
| EPS (diluted) | -0.2200 | -0.3200 | -0.0300 | -1.4300 | – | -0.0100 |
| Shares (diluted) | $18.12M | $9.21M | $10.35M | $5.94M | – | $28.26M |